Tag: Hatch-Waxman Act
FDA's 180-Day Exclusivity: How It Helps First Generic Drug Applicants Cut Costs and Speed Up Access
The FDA's 180-day exclusivity gives the first generic drug maker to challenge a patent a head start on the market. But how does it really work-and why is it being changed? Learn how this rule shapes drug prices and access.
read more